The World Health Organization (WHO) has called for the elimination of cervical cancer as a
public health problem. Cervical cancer screening through human papillomavirus (HPV) …

A self-sampling human papillomavirus (HPV) test could improve the morbidity and mortality
of cervical cancer in Japan. However, its effectiveness and feasibility have not been …

In 2016, the Netherlands will switch, as first European country, from cytology-based to HPV-
based cervical cancer screening, with cytology triage for those with a positive HPV test. The …

High screening participation in the population is essential for optimal prevention of cervical
cancer. Offering a high‐risk human papillomavirus (HPV) self‐test has previously been …

Human papillomavirus (hpv) is the primary cause of cervical, anal, and other genital
cancers, which are preventable through screening and early treatment. Cervical cancer is a …

Objective To report a modelling study using local health care costs and epidemiological
inputs from a population-based program to access the cost-effectiveness of adopting hrHPV …

Objectives To evaluate the cost-effectiveness of human papillomavirus (HPV) DNA testing
(versus Papanicolaou (Pap)-based screening) for cervical cancer screening in Nicaragua …

Objective To determine the incremental costs and effects of different HPV testing strategies,
when compared to Papanicolau cytology (Pap), for cervical cancer screening in Mexico …

Background The effectiveness of cervical cancer screening programs is challenged by
suboptimal participation and coverage. Offering cervico-vaginal self-sampling for human …

Background Cervical cancer is a major global health issue, with 89% of cases occurring in
low-and middle-income countries (LMICs). Human papillomavirus (HPV) self-sampling tests …